May 12, 2008
Imclone Declines After Morgan Stanley Analyst Cuts Shares to `Underweight'
ImClone Systems Inc. dropped the most in eight months after an analyst at Morgan Stanley recommended that investors sell the shares in light of new research on the company's only product, the cancer drug ... via Bloomberg.com
Read full story from Bloomberg.com
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Vioxx claimants rush to join $4.85B settlement ... (from Jan '08) | 32 min | Jerimiah | 686 |
| Claims administrator: Interim payments in $4.85... | 1 hr | Dick In Ohio | 1049 |
| MPI Research cutting jobs in Mattawan | 7 hr | Former MPI E... | 18 |
| Cymbalta leads the way for Lilly (from Feb '07) | 7 hr | Stranger In ... | 234 |
| Merck to fund Vioxx settlement in August | 10 hr | Peggy | 1375 |
| Northwestern Memorial Hospital patient's compla... | 10 hr | Old RN | 2 |
| Johnson & Johnson buying Mentor for $1.07B | 12 hr | Anon Amous | 3 |
Leo
Most Popular